Page 2 - தடுப்பு மருந்துகள் பணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தடுப்பு மருந்துகள் பணி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தடுப்பு மருந்துகள் பணி Today - Breaking & Trending Today

Barrow targeted as area for 30,000 new jobs in UK steel


BARROW has been highlighted as a location targeted for 30,000 new jobs in UK steel fabrication to build approximately 300 giant wind turbines each year.
This comes following demand in order to meet the net zero carbon by 2050 target and is vital for levelling up coastal and industrial areas says GMB.
As things stand, without a Renewables Development Authority to develop UK capacity, these steel fabrication jobs are destined to be in Asia with the only role for UK workers being to pay for them which is unnecessary and politically unacceptable says GMB Scotland.
Up to 30,000 new jobs are required in the UK steel fabrication sector to build the approximately 300 giant offshore wind turbines each year every year to meet official UK net zero carbon emissions electricity new capacity by 2050. ....

Western Isles , Eilean Siar , United Kingdom , United Kingdom General , Great Yarmouth , Milford Haven , North Sea , Oceans General , King Lynn , Gary Smith , Docklands Development Corporation , Vaccines Task , Climate Change Committee , Renewables Development Authority , Vaccines Taskforce , மேற்கு தீவுகள் , ஈயைலந் சீயார் , ஒன்றுபட்டது கிஂக்டம் , மூச்சுத் திணறல் , ஒன்றுபட்டது கிஂக்டம் ஜநரல் , நன்று யர்மவுத் , மில்ஃபோர்ட் புகலிடம் , வடக்கு கடல் , பெருங்கடல்கள் ஜநரல் , கிங் லின் , கேரி ஸ்மித் ,

Investegate |CureVac Announcements | CureVac: CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020


DGAP-News: CureVac
/ Key word(s): Quarter Results/Annual Results
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
15.04.2021 / 13:30
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
-
COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission
- Pivotal Phase 2b/3 in Europe and Latin America fully recruited with over 40,000 participants. Interim analysis for vaccine efficacy expected in Q2 2021
- Phase 2a trial in Peru and Panama amended for addition of secondary endpoint for vaccine efficacy in total population with a focus on participants over the age of 60 ....

United States , United Kingdom , South Africa , South African , Rentschler Biopharma , Antony Blanc , Wacker Chemie , Sarah Fakih , Franz Werner Haas , Eli Lilly , Pierre Kemula , Contract Development , Vaccine Program , Coalition For Epidemic Preparedness Innovations , Manufacturing Organization , Celonic Group , Vaccines Task , European Union , Program Products , European Investment Bank , Society For Immunotherapy Of Cancer , German Federal Ministry Of Education , European Commission , Exchange Commission , European Medicines Agency , Partnership Agreements ,

CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020


CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
- COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission
- Pivotal Phase 2b/3 in Europe and Latin America fully recruited with over 40,000 participants. Interim analysis for vaccine efficacy expected in Q2 2021
- Phase 2a trial in Peru and Panama amended for addition of secondary endpoint for vaccine efficacy in total population with a focus on participants over the age of 60
- CVnCoV demonstrates, in preclinical challenge study, full protection from infections with Variant of Concern B.1.351 (South Africa variant) ....

United States , United Kingdom , South Africa , South African , Rentschler Biopharma , Antony Blanc , Wacker Chemie , Sarah Fakih , Franz Werner Haas , Eli Lilly , Pierre Kemula , Contract Development , Vaccine Program , Coalition For Epidemic Preparedness Innovations , Manufacturing Organization , Celonic Group , Vaccines Task , European Union , Program Products , European Investment Bank , Society For Immunotherapy Of Cancer , German Federal Ministry Of Education , European Commission , Exchange Commission , European Medicines Agency , Partnership Agreements ,